Which medication(s) should be injected for a stellate ganglion block?

Stellate Ganglion Block: Medication Selection

For a stellate ganglion block, inject a local anesthetic—typically bupivacaine 0.25% or lidocaine 2%—with volumes ranging from 4-10 mL depending on the clinical indication and technique used.

Primary Injectate Options

Local Anesthetics (Core Component)

The stellate ganglion block requires a local anesthetic as the primary agent to achieve sympathetic blockade. Based on current practice patterns and available evidence:

• Bupivacaine 0.25%: Commonly used for longer-duration blockade 1, 2, 3
• Lidocaine 2%: Frequently employed, often with epinephrine 1, 4
• Ropivacaine: Emerging as an alternative with favorable safety profile 2

Volume Considerations

The volume administered varies by indication and technique:

• Standard diagnostic/therapeutic blocks: 2-10 mL of local anesthetic 1, 3, 4
• Continuous infusions: Starting doses of approximately 12 mg/h for ropivacaine or 100 mg/h for lidocaine 2

Adjuvant Medications

Corticosteroids (Optional)

While not universally required, corticosteroids may be added for certain indications:

• Dexamethasone sodium phosphate (preservative-free): 10 mg has been used in combination protocols for conditions like PTSD and chronic pain 1
• The evidence base for routine steroid addition to stellate ganglion blocks is limited compared to other regional techniques 5

Epinephrine

• Epinephrine-containing solutions: Used to prolong block duration and reduce systemic absorption 1

Clinical Context-Specific Protocols

For Ventricular Arrhythmias (Electrical Storm)

The most robust evidence exists for this indication:

• Bupivacaine alone or combined with lidocaine injected with good local anesthetic spread in the vicinity of the left stellate ganglion or bilaterally 3
• Continuous infusions: Ropivacaine and lidocaine are the most commonly used agents, with starting doses of 12 mg/h and 100 mg/h respectively 2

For Pain Syndromes (CRPS, Central Post-Stroke Pain, Chronic Pain)

• 2% lidocaine (2 mL) has been successfully used for central post-stroke pain 4
• Combination therapy: 4 mL preservative-free lidocaine 2% with epinephrine + 1 mL preservative-free bupivacaine 0.25% + 10 mg preservative-free dexamethasone has shown efficacy for complex pain conditions 1
• The American Society of Anesthesiologists supports stellate ganglion blocks for CRPS as part of multimodal treatment 6

For Hot Flashes/Autonomic Symptoms

• Procaine has been used as an alternative to bupivacaine, with proponents citing lower toxicity risk and comparable efficacy 7

Critical Safety Considerations

Always use preservative-free formulations when available, particularly when adding adjuvants like dexamethasone or when performing neuraxial-adjacent procedures 1.

The procedure demonstrates a favorable safety profile with minimal major complications reported across multiple studies 2, 3. However, practitioners should:

• Monitor for transient complications including Horner's syndrome (expected), hoarseness, and dysphagia 3
• Be prepared for potential vasovagal reactions 8
• Consider anticoagulation status, though stellate ganglion blocks appear safer than thoracic epidural approaches in anticoagulated patients (63% of patients in one series were fully anticoagulated) 2

Practical Algorithm

1. Select primary local anesthetic: Bupivacaine 0.25% (4-10 mL) for longer duration OR Lidocaine 2% (4-10 mL) for faster onset
2. Consider epinephrine addition: Particularly with lidocaine formulations
3. Evaluate need for corticosteroid: Add preservative-free dexamethasone 10 mg for inflammatory or complex pain conditions
4. Adjust volume: Based on imaging guidance and spread visualization
5. For continuous techniques: Initiate ropivacaine 12 mg/h or lidocaine 100 mg/h infusions

The choice between agents should prioritize the clinical indication, desired duration of effect, and institutional availability, with ultrasound guidance strongly recommended for accuracy and safety 4.